Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
HOLX Hologic	$64.83 -0.7%	$60.45	$51.90 ▼ $84.67	$14.45B	0.55	2.37 million shs	236,728 shs
HQY HealthEquity	$100.15 -1.1%	$99.20	$65.01 ▼ $116.65	$8.66B	0.49	857,360 shs	78,126 shs
HSIC Henry Schein	$74.53 +0.1%	$70.34	$60.56 ▼ $82.49	$9.07B	0.87	1.72 million shs	51,606 shs
MCK McKesson	$714.51 +1.3%	$713.06	$464.42 ▼ $736.96	$89.43B	0.48	921,183 shs	48,471 shs

Elon Musk's Next Move

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
HOLX Hologic	-0.05%	+1.60%	+5.31%	+5.85%	-11.19%
HQY HealthEquity	-1.56%	-2.59%	-1.49%	+22.07%	+18.10%
HSIC Henry Schein	0.00%	+2.32%	+7.07%	+11.85%	+13.54%
MCK McKesson	-2.79%	-1.88%	-2.16%	-1.54%	+20.66%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
HOLX Hologic	4.7765 of 5 stars	3.2	4.0	0.0	4.3	3.5	3.3	1.3
HQY HealthEquity	3.6034 of 5 stars	3.5	3.0	0.0	0.0	2.2	2.5	1.9
HSIC Henry Schein	3.014 of 5 stars	1.3	1.0	0.0	3.4	2.8	1.7	1.9
MCK McKesson	4.7183 of 5 stars	2.4	5.0	3.3	3.0	2.9	2.5	1.3

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
HOLX Hologic	2.41	Hold	$77.42	19.42% Upside
HQY HealthEquity	3.00	Buy	$118.09	17.91% Upside
HSIC Henry Schein	2.64	Moderate Buy	$79.30	6.40% Upside
MCK McKesson	2.86	Moderate Buy	$696.42	-2.53% Downside

Current Analyst Ratings Breakdown

Latest MCK, HOLX, HQY, and HSIC Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
6/11/2025	MCK McKesson	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$745.00 ➝ $770.00
6/5/2025	HQY HealthEquity	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$112.00 ➝ $125.00
6/5/2025	HQY HealthEquity	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$98.00 ➝ $115.00
6/4/2025	HQY HealthEquity	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral ➝ Neutral	$94.00 ➝ $104.00
6/4/2025	HQY HealthEquity	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$112.00 ➝ $117.00
6/4/2025	HQY HealthEquity	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Market Outperform ➝ Market Outperform	$110.00 ➝ $117.00
6/4/2025	HQY HealthEquity	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$110.00 ➝ $125.00
6/3/2025	MCK McKesson	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Equal Weight ➝ Equal Weight	$691.00 ➝ $766.00
5/27/2025	HOLX Hologic	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Hold ➝ Hold
5/22/2025	HQY HealthEquity	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform	$105.00 ➝ $112.00
5/13/2025	HOLX Hologic	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$77.00 ➝ $70.00

(Data available from 7/3/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
HOLX Hologic	$4.03B	3.58	$5.46 per share	11.88	$22.09 per share	2.93
HQY HealthEquity	$1.20B	7.22	$4.15 per share	24.13	$24.56 per share	4.08
HSIC Henry Schein	$12.67B	0.72	$7.34 per share	10.16	$32.33 per share	2.31
MCK McKesson	$359.05B	0.25	$38.15 per share	18.73	($13.52) per share	-52.85

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
HOLX Hologic	$789.50M	$2.37	27.36	14.03	2.39	13.83%	19.71%	10.87%	8/4/2025 (Estimated)
HQY HealthEquity	$96.70M	$1.37	73.10	35.26	1.58	9.80%	11.01%	6.77%	9/2/2025 (Estimated)
HSIC Henry Schein	$390M	$3.20	23.29	14.85	2.40	3.21%	14.87%	5.82%	8/5/2025 (Estimated)
MCK McKesson	$3.30B	$25.83	27.67	19.50	1.45	0.92%	-201.12%	5.83%	8/6/2025 (Estimated)

Latest MCK, HOLX, HQY, and HSIC Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
6/3/2025	Q1 2026	HQY HealthEquity	$0.81	$0.97	+$0.16	$0.61	$322.25 million	$330.80 million
5/8/2025	Q4 2025	MCK McKesson	$9.83	$10.12	+$0.29	$10.01	$94.00 billion	$90.82 billion
5/5/2025	Q1 2025	HSIC Henry Schein	$1.11	$1.15	+$0.04	$0.88	$3.24 billion	$3.17 billion
5/1/2025	Q2 2025	HOLX Hologic	$1.02	$1.03	+$0.01	-$0.08	$1.00 billion	$1.01 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
HOLX Hologic	N/A	N/A	N/A	N/A	N/A
HQY HealthEquity	N/A	N/A	N/A	N/A	N/A
HSIC Henry Schein	N/A	N/A	N/A	N/A	N/A
MCK McKesson	$2.84	0.40%	N/A	10.99%	17 Years

Latest MCK, HOLX, HQY, and HSIC Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
5/1/2025	MCK McKesson	quarterly	$0.71	0.4%	6/2/2025	6/2/2025	7/1/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
HOLX Hologic	0.54	3.24	2.52
HQY HealthEquity	0.50	4.06	4.06
HSIC Henry Schein	0.50	1.38	0.75
MCK McKesson	N/A	0.90	0.53

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
HOLX Hologic	94.73%
HQY HealthEquity	99.55%
HSIC Henry Schein	96.62%
MCK McKesson	85.07%

Insider Ownership

Company	Insider Ownership
HOLX Hologic	1.88%
HQY HealthEquity	1.50%
HSIC Henry Schein	1.08%
MCK McKesson	0.11%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
HOLX Hologic	7,063	222.85 million	218.66 million	Optionable
HQY HealthEquity	3,120	86.47 million	85.18 million	Optionable
HSIC Henry Schein	25,000	121.72 million	120.41 million	Optionable
MCK McKesson	45,000	125.11 million	124.97 million	Optionable

MCK, HOLX, HQY, and HSIC Headlines

Recent News About These Companies

Teacher Retirement System of Texas Has $47.64 Million Stock Holdings in McKesson Corporation (NYSE:MCK)

3 hours ago | marketbeat.com

Q1 Earnings Estimate for McKesson Issued By Leerink Partnrs

3 hours ago | marketbeat.com

First Horizon Advisors Inc. Has $13.50 Million Position in McKesson Corporation (NYSE:MCK)

4 hours ago | marketbeat.com

Ameritas Advisory Services LLC Cuts Stock Holdings in McKesson Corporation (NYSE:MCK)

July 3 at 4:47 AM | marketbeat.com

Leerink Partnrs Has Pessimistic View of McKesson Q4 Earnings

July 3 at 2:59 AM | americanbankingnews.com

McKesson (MCK) Stock Falls Amid Market Uptick: What Investors Need to Know

July 2 at 7:01 PM | zacks.com

These Top 4 Women-Run Company Stocks Are Quietly Beating the Market

July 2 at 12:15 PM | zacks.com

Q4 Earnings Forecast for McKesson Issued By Leerink Partnrs

July 2 at 8:44 AM | marketbeat.com

WCM Investment Management LLC Acquires 603 Shares of McKesson Corporation (NYSE:MCK)

July 2 at 8:25 AM | marketbeat.com

Oregon Pacific Wealth Management LLC Purchases New Position in McKesson Corporation (NYSE:MCK)

July 2 at 7:41 AM | marketbeat.com

Yukon Wealth Management Inc. Purchases Shares of 1,065 McKesson Corporation (NYSE:MCK)

July 2 at 6:58 AM | marketbeat.com

Is McKesson (MCK) a Solid Growth Stock? 3 Reasons to Think "Yes"

July 1 at 1:45 PM | zacks.com

Zacks.com featured highlights include Agnico Eagle Mines, NetEase, Qifu Technology, UGI and McKesson

July 1 at 12:05 PM | finance.yahoo.com

Summit Trail Advisors LLC Acquires 603 Shares of McKesson Corporation (NYSE:MCK)

July 1 at 8:47 AM | marketbeat.com

McKesson Corporation (NYSE:MCK) Shares Acquired by Smith Group Asset Management LLC

July 1 at 8:10 AM | marketbeat.com

Vontobel Holding Ltd. Lowers Stock Holdings in McKesson Corporation (NYSE:MCK)

July 1 at 7:45 AM | marketbeat.com

WHO NEEDS THE FCC?: Court Holds Cell Numbers Are Residential Numbers for DNC Purposes in First Post-McKesson TCPA Ruling

July 1 at 7:03 AM | natlawreview.comN

Red Door Wealth Management LLC Makes New Investment in McKesson Corporation (NYSE:MCK)

July 1 at 5:58 AM | marketbeat.com

Allspring Global Investments Holdings LLC Sells 12,890 Shares of McKesson Corporation (NYSE:MCK)

July 1 at 4:35 AM | marketbeat.com

The Supreme Court Reins in Agency Power Again: What McKesson Means for TCPA Litigation

June 30 at 9:02 PM | natlawreview.comN

5 Top-Ranked Dividend Growth Stock Picks for the Second Half of 2025

June 30 at 11:00 AM | zacks.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

MCK, HOLX, HQY, and HSIC Company Descriptions

Hologic NASDAQ:HOLX

$64.83 -0.47 (-0.73%)

As of 10:15 AM Eastern

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. The company also offers breast cancer care solutions in the areas of radiology, breast surgery, pathology, and treatment, such as 3D digital mammography systems, image analytics software, reading workstations, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, specimen radiology, and connectivity solutions; and breast conserving surgery products. In addition, it provides MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids and polyps in the uterus; NovaSure Endometrial Ablation System to treat abnormal uterine bleeding; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; Acessa ProVu system to treat various fibroids; and CoolSeal portfolio, such as bipolar vessel sealing devices. Further, the company offers Horizon DXA, a dual energy X-ray system; and Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. It sells its products through direct sales, service forces, independent distributors, and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

HealthEquity NASDAQ:HQY

$100.15 -1.13 (-1.12%)

As of 10:15 AM Eastern

HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers flexible spending accounts; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves clients through a direct sales force; benefits brokers and advisors; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. HealthEquity, Inc. was incorporated in 2002 and is based in Draper, Utah.

Henry Schein NASDAQ:HSIC

$74.53 +0.05 (+0.06%)

As of 10:15 AM Eastern

Henry Schein, Inc. provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products, such as branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners; and value-added practice solutions comprising practice consultancy, education, revenue cycle management and financial services, e-services, practice technology, and network and hardware services, as well as consulting, and continuing education services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

McKesson NYSE:MCK

$714.51 +9.06 (+1.28%)

As of 10:15 AM Eastern

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time